Accolade, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended February 29, 2024
April 25, 2024 at 04:17 pm
Share
Accolade, Inc. reported earnings results for the fourth quarter and full year ended February 29, 2024. For the fourth quarter, the company reported sales was USD 124.83 million compared to USD 99.03 million a year ago. Net loss was USD 7.51 million compared to USD 30.43 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.42 a year ago.
For the full year, sales was USD 414.29 million compared to USD 363.14 million a year ago. Net loss was USD 99.81 million compared to USD 459.65 million a year ago. Basic loss per share from continuing operations was USD 1.33 compared to USD 6.45 a year ago.
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, womenâs health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
ACCOLADE, INC. 
